Increase in activity of Na[+], K[+]-ATPase by Porphyrin compounds as treatment for dysnatremias caused by diabetes mellitus

ABSTRACT

Objective: The aim of this study was to test the action of Porphyrin compounds, Tetraphenylporphine sulfonate [TPPS], 5,10,15,20-Tetrakis [4-sulfonatophenyl] porphyrinato Iron[III] Chloride [FeTPPS] and 5,10,15,20-Tetrakis [4-sulfonatophenyl] porphyrinato Iron[III] nitrosyl Chloride [FeNOTPPS], on Na[+], K[+] -ATPase of cell membrane of erythrocytes